tert-Butyl 4-((6-chloropyridin-3-yl)methyl)-2-methylpiperazine-1-carboxylate

Catalog No. :
ACZHKN354
CAS No. :
1261230-47-0
Molecular Formula :
C16H24ClN3O2
Molecular Weight :
325.84

IUPAC Name:tert-butyl 4-((6-chloropyridin-3-yl)methyl)-2-methylpiperazine-1-carboxylate

tert-Butyl 4-((6-chloropyridin-3-yl)methyl)-2-methylpiperazine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$590.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 4-((6-chloropyridin-3-yl)methyl)-2-methylpiperazine-1-carboxylate
IUPAC Nametert-butyl 4-((6-chloropyridin-3-yl)methyl)-2-methylpiperazine-1-carboxylate
MDL No.MFCD18380476
Molecular FormulaC16H24ClN3O2
Molecular Weight325.84
SMILESO=C(N1C(C)CN(CC2=CC=C(Cl)N=C2)CC1)OC(C)(C)C
InChI KeyIVWRFMFTNGHGGH-UHFFFAOYSA-N
Synonym4-(6-Chloro-pyridin-3-ylmethyl)-2-methyl-piperazine-1-carboxylic acid tert-butyl ester
CAS No.1261230-47-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACZHKN354 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTVXW703 route compound structure diagram
    ACTVXW703120737-78-2 In Stock
  2. Plus
  3. ACCTJM471 route compound structure diagram
    ACCTJM47123100-12-1 In Stock
  4. Then
  5. ACZHKN354 route product structure diagram
    ACZHKN3541261230-47-0
Inquiry

2. ACZHKN354 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTVXW703 route compound structure diagram
    ACTVXW703120737-78-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZHKN354 route product structure diagram
    ACZHKN3541261230-47-0
Inquiry

Comments (0)